新生儿脑超声造影的可行性与安全性:以MRI为参考标准的前瞻性研究
该前瞻性研究纳入26例新生儿ICU中因临床需要接受MRI检查的新生儿,在暖箱旁行床旁脑超声及超声造影(CEUS),以MRI为参考标准。CEUS未发生生命体征显著改变或对比剂不良反应,检查时间短于MRI;CEUS对任何异常的敏感度为93.3%、特异度为100.0%,对急性和慢性缺血的敏感度分别为87.5%和100.0%、特异度均为100.0%,但对硬膜下及脑实质出血的敏感度较差(22.2%–50.0%)。
要点
- 床旁新生儿脑CEUS安全可行,检查时间显著短于MRI(21.1±4.7 vs 74.2±34.8分钟,p<.001)。
- CEUS对任何异常的敏感度为93.3%、特异度为100.0%,与超声的86.7%敏感度、100.0%特异度相近。
- CEUS对急性/亚急性缺血敏感度87.5%、慢性缺血100.0%,特异度均100.0%;对硬膜下及脑实质出血敏感度仅22.2%–50.0%。
核心结论
- 新生儿床旁脑CEUS可行、安全,且比MRI更快速;CEUS相对于常规超声对缺血的潜在诊断价值有待进一步研究。
研究设计与样本
- 前瞻性研究,纳入26例新生儿ICU中因临床需要接受MRI检查的新生儿(男9例、女17例,平均年龄15.2±14.0天),在暖箱或婴儿床旁行脑超声及CEUS,以MRI为参考标准,由两名放射科医生独立评估超声和CEUS图像并对分歧达成共识,另由一名放射科医生评估MRI。
关键影像表现/征象
- CEUS检查后回顾性阅片发现1例缺血后再灌注,MRI未见,随后经增强CT证实。
- 超声和CEUS对任何异常的读者间一致性均几乎完美(κ=0.92和0.85)。
- 超声和CEUS对硬膜下及脑实质出血的敏感度均较差(22.2%–50.0%)。
诊断标准与关键数值
- 以MRI为参考标准,CEUS对任何异常的敏感度93.3%、特异度100.0%;超声对任何异常的敏感度86.7%、特异度100.0%。
- CEUS对急性或亚急性缺血的敏感度87.5%、特异度100.0%;对慢性缺血的敏感度100.0%、特异度100.0%。
- 超声和CEUS对硬膜下及脑实质出血的敏感度均为22.2%–50.0%。
- 超声对任何异常的读者间一致性κ=0.92,CEUS为κ=0.85。
临床应用与阅片要点
- 新生儿脑CEUS可在暖箱旁完成,无需搬动患儿,检查时间显著短于MRI(21.1±4.7 vs 74.2±34.8分钟,p<.001)。
- CEUS对缺血性病变的敏感度高于常规超声(任何异常93.3% vs 86.7%;急性/亚急性缺血87.5%),但两者对硬膜下及脑实质出血的敏感度均较差(22.2%–50.0%)。
- 作者认为CEUS相对于常规超声对缺血的潜在诊断价值有待进一步研究。
局限性
- 作者指出CEUS相对于常规超声的潜在诊断价值,尤其对缺血,有待进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. MRI is the reference standard for neonatal brain imaging, but it is expensive, time-consuming, potentially limited by availability and accessibility, and contraindicated in some patients. Transfontanelle neonatal head ultrasound is an excellent alternative but may be less sensitive and specific than MRI. Contrast-enhanced ultrasound (CEUS) has the potential to improve the capabilities of ultrasound. OBJECTIVE. The purpose of this study is to prospectively evaluate the feasibility, safety, and diagnostic performance of transfontanelle neonatal brain CEUS, with MRI used as the reference standard. METHODS. Neonates in the institutional neonatal ICU who were undergoing MRI as part of their clinical care were prospectively recruited to undergo portable brain ultrasound and CEUS for research purposes. Brain ultrasound and CEUS were performed portably without moving the patient from the isolette or crib in the neonatal ICU. Adverse events were recorded. Two radiologists independently evaluated ultrasound and CEUS images for abnormalities and then reached consensus regarding discrepancies. A separate radiologist reviewed MRI examinations. Sensitivity, specificity, and interreader agreement were evaluated, with MRI used as the reference. Qualitative post hoc image review was performed. RESULTS. Twenty-six neonates (nine boys and 17 girls; mean [± SD] age, 15.2 ± 14.0 days) were included. No significant alteration in patient vital signs or adverse reaction to the ultrasound contrast agent (UCA) occurred. The mean duration of the examination was significantly shorter for combined ultrasound and CEUS than for MRI (21.1 ± 4.7 vs 74.2 ± 34.8 minutes; p < .001). Interrater agreement for any abnormality was almost perfect for both ultrasound and CEUS (κ = 0.92 and 0.85, respectively). Sensitivity for any abnormality was 86.7% for ultrasound and 93.3% for CEUS; specificity was 100.0% for both. CEUS had sensitivity of 87.5% for acute or subacute ischemia and 100.0% for chronic ischemia; its specificity was 100.0% for acute or subacute ischemia and chronic ischemia. For both ultrasound and CEUS, sensitivity for subdural and intraparenchymal hemorrhage was poor (22.2-50.0%). On CEUS but not on MRI, post hoc review showed a case of postischemic hyperperfusion, which was confirmed by subsequently performed contrast-enhanced CT. CONCLUSION. The use of portable brain CEUS in neonates is feasible, safe, and more rapid than MRI. CLINICAL IMPACT. The potential diagnostic utility of brain neonatal CEUS relative to conventional ultrasound, particularly for ischemia, warrants further investigation.
引用
- Squires JH, Beluk NH, Lee VK, et al. Feasibility and Safety of Contrast-Enhanced Ultrasound of the Neonatal Brain: A Prospective Study Using MRI as the Reference Standard. AJR Am J Roentgenol. 2021. PMID: 34286594. doi:10.2214/AJR.21.26274
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。